Where Do We Stand in Stem Cell Therapy for the Management of Diabetes Mellitus?—A Scientometric Research Trend Analysis from 1990 to 2020

Stem cell therapy has been considered a promising strategy in the management of both type I and type II diabetes mellitus (DM) because of its immunomodulatory and regenerative capability to restore the beta cell number and function. Various modalities of cellular therapy like transplantation of panc...

Full description

Bibliographic Details
Main Authors: Sathish Muthu, Madhan Jeyaraman, Naveen Jeyaraman, Ramya Lakshmi Rajendran, Prakash Gangadaran
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Bioengineering
Subjects:
Online Access:https://www.mdpi.com/2306-5354/8/11/159